Search Results 261-270 of 24186 for In situ
Participation eligibility · Synovial sarcoma; · A SMARCB1-null tumor as determined by immunohistochemistry, fluorescent in situ hybridization, or other equivalent ...
... in situ cancer, lobular carcinoma of the breast in situ, cervical cancer in situ, atypical melanocytic hyperplasia or melanoma in situ are eligible ...
- Carcinoma in situ of the cervix, - Carcinoma in situ of the breast, - Incidental histological finding of prostate cancer 10. Participants with clinical ...
This is a phase II trial that will study how well tucatinib (ONT-380) and trastuzumab work in ... in situ, or Stage I uterine cancer). Subjects with known active ...
Drugs used in chemotherapy, such as docetaxel, doxorubicin, cyclophosphamide, paclitaxel, and gemcitabine work in different ways to stop tumor cells from ...
Lobular carcinoma in situ (LCIS) ... This study will recruit breast cancer patients and survivors to take part in an ongoing study of the issues and concerns ...
The purpose of this study is to examine the biology of Serous Tubal In Situ Carcinoma (STIC) lesions by conducting a proteomic and genomic analysis of STIC ...
Histologically or cytologically confirmed primary invasive breast carcinoma resected at time of original diagnosis. No ductal carcinoma in situ · Hormone ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Lobular ...
Drugs used in chemotherapy, such as temozolomide, work in ... No prior or concurrent malignancies at other sites except for surgically cured carcinoma in situ of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.